Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Standard

Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy. / Schoos, Ann-Marie Malby; Bullens, Dominique; Chawes, Bo Lund; Costa, Joana; De Vlieger, Liselot; DunnGalvin, Audrey; Epstein, Michelle M; Garssen, Johan; Hilger, Christiane; Knipping, Karen; Kuehn, Annette; Mijakoski, Dragan; Munblit, Daniel; Nekliudov, Nikita A; Ozdemir, Cevdet; Patient, Karine; Peroni, Diego; Stoleski, Sasho; Stylianou, Eva; Tukalj, Mirjana; Verhoeckx, Kitty; Zidarn, Mihaela; van de Veen, Willem.

I: Frontiers in Immunology, Bind 11, 568598, 2020.

Publikation: Bidrag til tidsskriftReviewForskningfagfællebedømt

Harvard

Schoos, A-MM, Bullens, D, Chawes, BL, Costa, J, De Vlieger, L, DunnGalvin, A, Epstein, MM, Garssen, J, Hilger, C, Knipping, K, Kuehn, A, Mijakoski, D, Munblit, D, Nekliudov, NA, Ozdemir, C, Patient, K, Peroni, D, Stoleski, S, Stylianou, E, Tukalj, M, Verhoeckx, K, Zidarn, M & van de Veen, W 2020, 'Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy', Frontiers in Immunology, bind 11, 568598. https://doi.org/10.3389/fimmu.2020.568598

APA

Schoos, A-M. M., Bullens, D., Chawes, B. L., Costa, J., De Vlieger, L., DunnGalvin, A., Epstein, M. M., Garssen, J., Hilger, C., Knipping, K., Kuehn, A., Mijakoski, D., Munblit, D., Nekliudov, N. A., Ozdemir, C., Patient, K., Peroni, D., Stoleski, S., Stylianou, E., ... van de Veen, W. (2020). Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy. Frontiers in Immunology, 11, [568598]. https://doi.org/10.3389/fimmu.2020.568598

Vancouver

Schoos A-MM, Bullens D, Chawes BL, Costa J, De Vlieger L, DunnGalvin A o.a. Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy. Frontiers in Immunology. 2020;11. 568598. https://doi.org/10.3389/fimmu.2020.568598

Author

Schoos, Ann-Marie Malby ; Bullens, Dominique ; Chawes, Bo Lund ; Costa, Joana ; De Vlieger, Liselot ; DunnGalvin, Audrey ; Epstein, Michelle M ; Garssen, Johan ; Hilger, Christiane ; Knipping, Karen ; Kuehn, Annette ; Mijakoski, Dragan ; Munblit, Daniel ; Nekliudov, Nikita A ; Ozdemir, Cevdet ; Patient, Karine ; Peroni, Diego ; Stoleski, Sasho ; Stylianou, Eva ; Tukalj, Mirjana ; Verhoeckx, Kitty ; Zidarn, Mihaela ; van de Veen, Willem. / Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy. I: Frontiers in Immunology. 2020 ; Bind 11.

Bibtex

@article{6189a281b85d4184a4b61817b0a266b6,
title = "Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy",
abstract = "IgE-mediated food allergies are caused by adverse immunologic responses to food proteins. Allergic reactions may present locally in different tissues such as skin, gastrointestinal and respiratory tract and may result is systemic life-threatening reactions. During the last decades, the prevalence of food allergies has significantly increased throughout the world, and considerable efforts have been made to develop curative therapies. Food allergen immunotherapy is a promising therapeutic approach for food allergies that is based on the administration of increasing doses of culprit food extracts, or purified, and sometime modified food allergens. Different routes of administration for food allergen immunotherapy including oral, sublingual, epicutaneous and subcutaneous regimens are being evaluated. Although a wealth of data from clinical food allergen immunotherapy trials has been obtained, a lack of consistency in assessed clinical and immunological outcome measures presents a major hurdle for evaluating these new treatments. Coordinated efforts are needed to establish standardized outcome measures to be applied in food allergy immunotherapy studies, allowing for better harmonization of data and setting the standards for the future research. Several immunological parameters have been measured in food allergen immunotherapy, including allergen-specific immunoglobulin levels, basophil activation, cytokines, and other soluble biomarkers, T cell and B cell responses and skin prick tests. In this review we discuss different immunological parameters and assess their applicability as potential outcome measures for food allergen immunotherapy that may be included in such a standardized set of outcome measures.",
author = "Schoos, {Ann-Marie Malby} and Dominique Bullens and Chawes, {Bo Lund} and Joana Costa and {De Vlieger}, Liselot and Audrey DunnGalvin and Epstein, {Michelle M} and Johan Garssen and Christiane Hilger and Karen Knipping and Annette Kuehn and Dragan Mijakoski and Daniel Munblit and Nekliudov, {Nikita A} and Cevdet Ozdemir and Karine Patient and Diego Peroni and Sasho Stoleski and Eva Stylianou and Mirjana Tukalj and Kitty Verhoeckx and Mihaela Zidarn and {van de Veen}, Willem",
note = "Copyright {\textcopyright} 2020 Schoos, Bullens, Chawes, Costa, De Vlieger, DunnGalvin, Epstein, Garssen, Hilger, Knipping, Kuehn, Mijakoski, Munblit, Nekliudov, Ozdemir, Patient, Peroni, Stoleski, Stylianou, Tukalj, Verhoeckx, Zidarn and van de Veen.",
year = "2020",
doi = "10.3389/fimmu.2020.568598",
language = "English",
volume = "11",
journal = "Frontiers in Immunology",
issn = "1664-3224",
publisher = "Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy

AU - Schoos, Ann-Marie Malby

AU - Bullens, Dominique

AU - Chawes, Bo Lund

AU - Costa, Joana

AU - De Vlieger, Liselot

AU - DunnGalvin, Audrey

AU - Epstein, Michelle M

AU - Garssen, Johan

AU - Hilger, Christiane

AU - Knipping, Karen

AU - Kuehn, Annette

AU - Mijakoski, Dragan

AU - Munblit, Daniel

AU - Nekliudov, Nikita A

AU - Ozdemir, Cevdet

AU - Patient, Karine

AU - Peroni, Diego

AU - Stoleski, Sasho

AU - Stylianou, Eva

AU - Tukalj, Mirjana

AU - Verhoeckx, Kitty

AU - Zidarn, Mihaela

AU - van de Veen, Willem

N1 - Copyright © 2020 Schoos, Bullens, Chawes, Costa, De Vlieger, DunnGalvin, Epstein, Garssen, Hilger, Knipping, Kuehn, Mijakoski, Munblit, Nekliudov, Ozdemir, Patient, Peroni, Stoleski, Stylianou, Tukalj, Verhoeckx, Zidarn and van de Veen.

PY - 2020

Y1 - 2020

N2 - IgE-mediated food allergies are caused by adverse immunologic responses to food proteins. Allergic reactions may present locally in different tissues such as skin, gastrointestinal and respiratory tract and may result is systemic life-threatening reactions. During the last decades, the prevalence of food allergies has significantly increased throughout the world, and considerable efforts have been made to develop curative therapies. Food allergen immunotherapy is a promising therapeutic approach for food allergies that is based on the administration of increasing doses of culprit food extracts, or purified, and sometime modified food allergens. Different routes of administration for food allergen immunotherapy including oral, sublingual, epicutaneous and subcutaneous regimens are being evaluated. Although a wealth of data from clinical food allergen immunotherapy trials has been obtained, a lack of consistency in assessed clinical and immunological outcome measures presents a major hurdle for evaluating these new treatments. Coordinated efforts are needed to establish standardized outcome measures to be applied in food allergy immunotherapy studies, allowing for better harmonization of data and setting the standards for the future research. Several immunological parameters have been measured in food allergen immunotherapy, including allergen-specific immunoglobulin levels, basophil activation, cytokines, and other soluble biomarkers, T cell and B cell responses and skin prick tests. In this review we discuss different immunological parameters and assess their applicability as potential outcome measures for food allergen immunotherapy that may be included in such a standardized set of outcome measures.

AB - IgE-mediated food allergies are caused by adverse immunologic responses to food proteins. Allergic reactions may present locally in different tissues such as skin, gastrointestinal and respiratory tract and may result is systemic life-threatening reactions. During the last decades, the prevalence of food allergies has significantly increased throughout the world, and considerable efforts have been made to develop curative therapies. Food allergen immunotherapy is a promising therapeutic approach for food allergies that is based on the administration of increasing doses of culprit food extracts, or purified, and sometime modified food allergens. Different routes of administration for food allergen immunotherapy including oral, sublingual, epicutaneous and subcutaneous regimens are being evaluated. Although a wealth of data from clinical food allergen immunotherapy trials has been obtained, a lack of consistency in assessed clinical and immunological outcome measures presents a major hurdle for evaluating these new treatments. Coordinated efforts are needed to establish standardized outcome measures to be applied in food allergy immunotherapy studies, allowing for better harmonization of data and setting the standards for the future research. Several immunological parameters have been measured in food allergen immunotherapy, including allergen-specific immunoglobulin levels, basophil activation, cytokines, and other soluble biomarkers, T cell and B cell responses and skin prick tests. In this review we discuss different immunological parameters and assess their applicability as potential outcome measures for food allergen immunotherapy that may be included in such a standardized set of outcome measures.

U2 - 10.3389/fimmu.2020.568598

DO - 10.3389/fimmu.2020.568598

M3 - Review

C2 - 33224138

VL - 11

JO - Frontiers in Immunology

JF - Frontiers in Immunology

SN - 1664-3224

M1 - 568598

ER -

ID: 257328833